Medicinal plants in diabetic nephropathy: bioactive compounds, mechanisms, and therapeutic potential

Diabetic nephropathy (DN) is known as one of the most critical microvascular complications associated with diabetes mellitus, and is a primary cause of chronic kidney disease and end-stage renal disease worldwide. Renal injury in DN is primarily driven by persistent hyperglycemia, which sequentially triggers oxidative stress, activation of innate immune signaling pathways, pro-inflammatory cytokine production, accumulation of advanced glycation end products, activation of the renin–angiotensin–aldosterone system (RAAS), and extracellular matrix deposition. Exisitng treatments, such as glycemic control, antihypertensive agents, and RAAS inhibitors, are efficacious in slowing disease progression. Alongside these standard therapies, medicinal plants and their bioactive constituents have garnered substantial attention as potential complementary approaches. The aim of this review is to highlight the therapeutic potential of medicinal plants and their phytoconstituents, leading to the prevention and management of DN, while elucidating associated pharmacological mechanisms. Several in vitro and in vivo studies have shown that various medicinal plants exert nephroprotective effects through antihyperglycemic, antioxidant, anti-inflammatory, anti-apoptotic, and lipid-lowering mechanisms, as well as by inactivating innate immune pathways. Notable phytoconstituents, including quercetin, rutin, curcumin, berberine, mangiferin, gallic acid, and thymoquinone, have demonstrated promising potential in enhancing renal biomarkers, reducing oxidative stress, suppressing inflammatory mediators, and preserving renal tissue structure. Altogether, medicinal plants emerge as promising multi-target therapeutic candidates for DN, warranting rigorous clinical trials to better evaluate their future therapeutic translation.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-12
DOI
https://doi.org/10.3389/fimmu.2026.1964602
Primary Topic
Natural Antidiabetic Agents Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Medicinal plants in diabetic nephropathy: bioactive compounds, mechanisms, and therapeutic potential

Fahmida Alam, Kamran Ul Baset, Samia Akther, Md. Josim Uddin et al.
Frontiers in Immunology
Natural Antidiabetic Agents Studies
article

Medicinal plants in diabetic nephropathy: bioactive compounds, mechanisms, and therapeutic potential

Fahmida Alam, Kamran Ul Baset, Samia Akther, Md. Josim Uddin, Sumaiya Akter Annie, Tahmeed Rezwan Shushmoy, Md. Abeduzzaman Anon, Md. Shah Amran
article en

Abstract

Diabetic nephropathy (DN) is known as one of the most critical microvascular complications associated with diabetes mellitus, and is a primary cause of chronic kidney disease and end-stage renal disease worldwide. Renal injury in DN is primarily driven by persistent hyperglycemia, which sequentially triggers oxidative stress, activation of innate immune signaling pathways, pro-inflammatory cytokine production, accumulation of advanced glycation end products, activation of the renin–angiotensin–aldosterone system (RAAS), and extracellular matrix deposition. Exisitng treatments, such as glycemic control, antihypertensive agents, and RAAS inhibitors, are efficacious in slowing disease progression. Alongside these standard therapies, medicinal plants and their bioactive constituents have garnered substantial attention as potential complementary approaches. The aim of this review is to highlight the therapeutic potential of medicinal plants and their phytoconstituents, leading to the prevention and management of DN, while elucidating associated pharmacological mechanisms. Several in vitro and in vivo studies have shown that various medicinal plants exert nephroprotective effects through antihyperglycemic, antioxidant, anti-inflammatory, anti-apoptotic, and lipid-lowering mechanisms, as well as by inactivating innate immune pathways. Notable phytoconstituents, including quercetin, rutin, curcumin, berberine, mangiferin, gallic acid, and thymoquinone, have demonstrated promising potential in enhancing renal biomarkers, reducing oxidative stress, suppressing inflammatory mediators, and preserving renal tissue structure. Altogether, medicinal plants emerge as promising multi-target therapeutic candidates for DN, warranting rigorous clinical trials to better evaluate their future therapeutic translation.

Frontiers in ImmunologyVol. 17
Independent University, Bangladesh (BD)
Good health and well-being
Natural Antidiabetic Agents Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon